TY - JOUR A1 - An, Yohan A1 - Lee, Ji-Hyun A1 - Lim, Joonoh A1 - Youk, Jeonghwan A1 - Park, Seongyeol A1 - Park, Ji-Hyung A1 - Yi, Kijong A1 - Kim, Taewoo A1 - Nam, Chang Hyun A1 - Lee, Won Hee A1 - Oh, Soo A A1 - Bae, Yoo Jin A1 - Klompstra, Thomas M. A1 - Lee, Haeun A1 - Han, Jinju A1 - Lee, Junehwak A1 - Park, Jung Woo A1 - Kim, Jie-Hyun A1 - Kim, Hyunki A1 - Snippert, Hugo A1 - Koo, Bon-Kyoung A1 - Ju, Young Seok T1 - APOBEC3A drives deaminase mutagenesis in human gastric epithelium Y1 - 2025/10/01 JF - Genome Research JO - Genome Research SP - 2158 EP - 2172 DO - 10.1101/gr.280338.124 VL - 35 IS - 10 UR - http://genome.cshlp.org/content/35/10/2158.abstract N2 - Cancer genomes frequently carry apolipoprotein B mRNA editing catalytic polypeptide-like (APOBEC)-associated DNA mutations, suggesting APOBEC enzymes as innate mutagens during cancer initiation and evolution. However, the pure mutagenic impacts of the specific enzymes among this family remain unclear in human normal cell lineages. Here, we investigate the comparative mutagenic activities of APOBEC3A and APOBEC3B, through whole-genome sequencing of human normal gastric organoid lines carrying doxycycline-inducible APOBEC expression cassettes. Our findings demonstrate that transcriptional upregulation of APOBEC3A leads to the acquisition of a massive number of genomic mutations in just a few cell cycles. In contrast, despite clear deaminase activity and DNA damage, APOBEC3B upregulation does not generate a significant increase in mutations in the gastric epithelium. APOBEC3B-associated mutagenesis remains minimal even in the context of TP53 inactivation. Further analysis of the mutational landscape following APOBEC3A upregulation reveals a detailed spectrum of APOBEC3A-associated mutations, including indels, primarily 1 bp deletions, clustered mutations, and evidence of selective pressures acting on cells carrying the mutations. Our observations provide a clear foundation for understanding the mutational impact of APOBEC enzymes in human cells. ER -